SCHEDULE: FMR LLC, Abigail Johnson Disclose 5.4% Harmony Biosciences Stake
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have jointly disclosed a beneficial ownership of 5.4% in Harmony Biosciences Holdings Inc. common stock as of December 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson beneficially own an aggregate of 3,112,812.16 shares of Harmony Biosciences Holdings Inc. common stock.
- This ownership represents 5.4% of the company's total outstanding common stock.
- FMR LLC holds sole voting power over 3,109,042 shares and sole dispositive power over all 3,112,812.16 shares.
- Abigail P. Johnson is deemed to beneficially own the same shares due to her role as Director, Chairman, CEO, and predominant owner of FMR LLC.
- The shares are reported as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of Harmony Biosciences Holdings Inc.
- This filing is Amendment No. 7 to a Schedule 13G, indicating previous beneficial ownership disclosures by FMR LLC and Abigail P. Johnson.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine disclosure of a significant, but not controlling, institutional stake. The continued presence of a major asset manager like FMR LLC is generally a positive signal, indicating ongoing investment interest.
Positives
- The continued presence of a significant institutional investor like FMR LLC, holding a 5.4% stake, signals ongoing institutional confidence in Harmony Biosciences Holdings Inc.
- The ownership is stated to be held in the ordinary course of business, suggesting a long-term investment perspective rather than an activist or control-seeking agenda.
Negatives
- No specific negative information related to Harmony Biosciences' operations or financial performance is disclosed in this beneficial ownership report.
Risks
- No specific risks related to Harmony Biosciences' operations or financial performance are mentioned in this beneficial ownership report.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Harmony Biosciences Holdings Inc.'s future performance or operations.
Industry Context
StockSavvy.ai notes that FMR LLC, a major investment management firm, maintaining a 5.4% stake in Harmony Biosciences Holdings Inc. signals continued institutional interest in the biotechnology or pharmaceutical sector, particularly in companies like Harmony Biosciences. This level of ownership by a prominent asset manager can be viewed positively by the market, suggesting a degree of confidence in the company's long-term prospects.
Comparison to Industry Standards
- This filing does not contain performance metrics or operational data that would allow for a direct comparison to industry standards or specific comparable companies/projects.
Related Party Transactions
- FMR LLC and Abigail P. Johnson, as Chairman and CEO of FMR LLC and a predominant owner, are filing jointly, indicating a related party relationship in their beneficial ownership disclosure.
- FMR LLC holds shares through various subsidiaries, including FIAM LLC, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, which are related entities.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially reinforcing confidence in the company.
- Management: Awareness of a large, non-activist institutional holder, which can influence strategic decisions and investor relations.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000003) was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000038) for Abigail P. Johnson was incorporated by reference. |
| 2025-12-31 | Date of event which requires filing of this statement, representing the beneficial ownership reported as of this date. |
| 2026-02-04 | Date of the joint filing agreement and signatures for this Schedule 13G Amendment No. 7. |
Recommendation
holdThe filing is a routine disclosure of beneficial ownership by a major institutional investor. While the continued presence of FMR LLC is a positive indicator of institutional confidence, it does not provide new operational or financial data to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and consider this information as part of a broader analysis of Harmony Biosciences' fundamentals and market conditions.
Keywords
Harmony Biosciences Holdings Inc, HBI, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, SEC Filing, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.